References
- Berger H, Gagnon R, Sermer M. SOGC clinical practice guideline in 2016: diabetes in pregnancy. Chinese General Practice; 2016.
- Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
- López-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res. 2001;34(10):1227–1235.
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
- Crane FL, Navas P. The diversity of coenzyme Q function. Mol Aspects Med. 1997;18(1):S1.
- Garrido-Maraver J, Cordero MD, De L, et al. Coenzyme Q10 therapy. Mol Syndromol. 2014;5(3–4):187.
- Langsjoen P, Langsjoen P, Willis R, et al. Treatment of essential hypertension with coenzyme Q 10. Mol Aspects Med. 1994;15 Suppl(3):S265.
- Yokoyama H, Lingle DM, Crestanello JA, et al. Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. Surgery. 1996;120(2):189–196.
- Das S, Das S, Das DK. Coenzyme Q 9/Q 10 and the healthy heart. Humana Press; 2010.
- Zhu ZG, Sun MX, Zhang WL, et al. The efficacy and safety of coenzyme Q10 in Parkinson’s disease: a meta-analysis of randomized controlled trials. Neurol Sci. 2016;38(2):1–10.
- Ferrante RJ Method of using coenzyme Q 10 to treat Huntington’s disease. US; 2011.
- Yan J, Xu X. Relationships between changes of antioxidant in placenta and the pathogenesis of preeclampsia. Zhong Hua Fu Chan Ke Za Zhi. 2012;47(6):412–417.
- Teran E, Racines-Orbe M, Vivero S, et al. Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Radic Biol Med. 2003;35(11):1453–1456.
- Teran E, Vivero S, Racines-Orbe M, et al. Coenzyme Q10 is increased in placenta and cord blood during preeclampsia. Biofactors. 2005;25(1–4):153–158.
- Teran E, Hernandez I, Nieto B, et al. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2009;105(1):43–45.
- Mooi E, Sarstedt M. A concise guide to market research. Springer; 2011.
- López-Jaramillo P, Arenas WD, García RG, et al. The role of the L-arginine-nitric oxide pathway in preeclampsia. Ther Adv Cardiovasc Dis. 2008;2(4):261.
- Zhang Y, Liu F, Chen S, et al. Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model. Eur J Obstet & Gynecol. 2015;188:51–55.
- Alasztics B, Kukor Z, Pánczél Z, et al. The pathophysiology of preeclampsia in view of the two-stage model. Orv Hetil. 2012;153(30):1167–1176.
- Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(SupplA):32–37.
- Cardoso PM, Surve S. The effect of vitamin E and vitamin C on the prevention of preeclampsia and newborn outcome: a case-control study. J Obstet Gynaecol India. 2016;66(Suppl 1):271.
- Polyzos NP, Tzioras S, Mauri D, et al. Combined vitamin C and E supplementation for Preeclampsia: no significant effect but significant heterogeneity. Hypertens Pregnancy. 2012;31(3):375–376.
- Rahmanian M, Aghayan S, Ghorbani R. Effect of combined vitamin C and E supplementation for preventing preeclampsia and some outcomes of pregnancy in Nulliparous women. Iranian J Obstet Gynecol Infertility. 2011;14(1).
- Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Pregnancy. 2002;21(3):205–223.
- Ouyang YQ, Li SJ, Zhang Q, et al. Interactions between inflammatory and oxidative stress in preeclampsia. Hypertens Pregnancy. 2009;28(1):56.
- Abad C, Proverbio T, Piñero S, et al. Preeclampsia, placenta, oxidative stress, and PMCA. Hypertens Pregnancy. 2012;31(4):427–441.